Advertisement
UK markets close in 5 hours 46 minutes

  • FTSE 100

    7,827.97
    -49.08 (-0.62%)
     

  • FTSE 250

    19,273.37
    -177.30 (-0.91%)
     

  • AIM

    740.95
    -4.34 (-0.58%)
     

  • GBP/EUR

    1.1676
    -0.0007 (-0.06%)
     

  • GBP/USD

    1.2450
    +0.0012 (+0.09%)
     

  • Bitcoin GBP

    52,017.19
    +2,672.40 (+5.42%)
     

  • CMC Crypto 200

    1,332.09
    +19.47 (+1.51%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CRUDE OIL

    83.19
    +0.46 (+0.56%)
     

  • GOLD FUTURES

    2,396.10
    -1.90 (-0.08%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,697.57
    -139.83 (-0.78%)
     

  • CAC 40

    7,977.40
    -45.86 (-0.57%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

BUZZ-GlaxoSmithKline: gains as Pfizer bid talk resurfaces

Reuters - UK Focus

** GlaxoSmithKline (Other OTC: GLAXF - news) up 3.4 pct in decent volume as talk resurfaces in newspaper market reports that Pfizer might bid for the British drugmaker (£19-a-share cash offer), after failing to win AstraZeneca (NYSE: AZN - news) last year

** (Link:http://bit.ly/1hkxgyY) (Link:http://bit.ly/1Nc7x5V)

** Pfizer (NYSE: PFE - news) spokesman says company doesn't comment on market speculation and rumour

** Idea of a Pfizer move on GSK first mooted by Berenberg Bank last August, with Deutsche Bank (Xetra: 514000 - news) outlining merits of creating "PfizerKline" in research note in May

** Despite Pfizer's readiness to do deals, scepticism remains high given likely political resistance to takeover of Britain's biggest pharmaceutical company

ADVERTISEMENT

** GSK third-top riser on FTSE 100 & most actively traded stock on the index, with nearly all of its 90-day daily avg having gone through c.3 hours before the close

(RM (LSE: RM.L - news) : ben.hirschler.thomsonreuters.com@reuters.net)